KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash & Current Investments: 2009-2024

Historic Cash & Current Investments for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $1.0 billion.

  • Exact Sciences' Cash & Current Investments fell 1.77% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 billion, marking a year-over-year increase of 8.48%. This contributed to the annual value of $1.0 billion for FY2024, which is 33.48% up from last year.
  • Exact Sciences' Cash & Current Investments amounted to $1.0 billion in FY2024, which was up 33.48% from $777.6 million recorded in FY2023.
  • Exact Sciences' 5-year Cash & Current Investments high stood at $1.8 billion for FY2020, and its period low was $632.1 million during FY2022.
  • Over the past 3 years, Exact Sciences' median Cash & Current Investments value was $777.6 million (recorded in 2023), while the average stood at $815.9 million.
  • As far as peak fluctuations go, Exact Sciences' Cash & Current Investments spiked by 468.50% in 2020, and later tumbled by 44.00% in 2021.
  • Yearly analysis of 5 years shows Exact Sciences' Cash & Current Investments stood at $1.8 billion in 2020, then slumped by 44.00% to $1.0 billion in 2021, then crashed by 38.66% to $632.1 million in 2022, then increased by 23.03% to $777.6 million in 2023, then soared by 33.48% to $1.0 billion in 2024.